STRIDE: Semaglutide Shows it Has Legs in Peripheral Artery Disease

(MedPage Today) — CHICAGO — Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building its positions in peripheral artery disease (PAD) and with an oral formulation, based on two major…